Clinical trial
Diacylglycerol, Extracellular Vesicles, and Liver Energy Metabolism in Fasting-Induced Insulin Resistance
NCT07928297 is registered in ClinicalTrials.gov with German Diabetes Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Diacylglycerol, Extracellular Vesicles, and Liver Energy Metabolism in Fasting-Induced Insulin Resistance
- Lead sponsor
- German Diabetes Center
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- January 31, 2027
- Completion date
- July 31, 2028
- Enrollment
- 18 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
fasting-induced insulin resistance, insulin resistance
Arms
As registered; 2 arms.
-
60-hour Fasting
Participants undergo 60 hours of complete fasting under medical supervision. At the end of the fasting period, insulin sensitivity and metabolic responses are assessed using a two-step hyperinsulinemic-euglycemic clamp, stable isotope tracers, magnetic resonance spectroscopy, indirect calorimetry, blood and urine sampling, and skeletal muscle and subcutaneous adipose tissue biopsies.
-
Control (12-hour Overnight Fasting)
Participants undergo a standard 12-hour overnight fast before metabolic assessments, without prolonged fasting. The same principal metabolic and tissue assessments are performed as in the prolonged fasting condition, allowing within-participant comparison of insulin sensitivity, tissue lipid metabolism, and molecular responses.
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Skeletal muscle plasma membrane sn-1,2-diacylglycerol content
Difference in plasma membrane-associated sn-1,2-diacylglycerol (DAG) stereoisomer content in skeletal muscle between the 60-hour fasting condition and the control condition, assessed in basal vastus lateralis muscle biopsies.
Lead sponsor's other trials
German Diabetes Center, most recent start first.
+25 more trials
Similar trials
Same condition (Insulin Resistance) and phase, most recent start first.
+1,532 more trials See the condition page